Literature DB >> 10579449

Incidence of symptomatic toxoplasma eye disease: aetiology and public health implications.

R E Gilbert1, D T Dunn, S Lightman, P I Murray, C E Pavesio, P D Gormley, J Masters, S P Parker, M R Stanford.   

Abstract

Ocular disease is the commonest disabling consequence of toxoplasma infection. Incidence and lifetime risk of ocular symptoms were determined by ascertaining affected patients in a population-based, active reporting study involving ophthalmologists serving a population of 7.4 million. Eighty-seven symptomatic episodes were attributed to toxoplasma infection. Bilateral visual acuity of 6/12 or less was found in seven episodes (8%) and was likely to have been transient in most cases. Black people born in West Africa had a 100-fold higher incidence of symptoms than white people born in Britain. Only two patients reported symptoms before 10 years of age. The estimated lifetime risk of symptoms in British born individuals (52% of all episodes) was 18/100000 (95% confidence interval: 10.8-25.2). The low risk and mild symptoms in an unscreened British population indicate limited potential benefits of prenatal or postnatal screening. The late age at presentation suggests a mixed aetiology of postnatally acquired and congenital infection for which primary prevention may be appropriate, particularly among West Africans.

Entities:  

Mesh:

Year:  1999        PMID: 10579449      PMCID: PMC2810761          DOI: 10.1017/s0950268899002800

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  30 in total

1.  Is ocular toxoplasmosis caused by prenatal or postnatal infection?

Authors:  R E Gilbert; M R Stanford
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

2.  Genetic approaches to studying virulence and pathogenesis in Toxoplasma gondii.

Authors:  L David Sibley; Dana G Mordue; Chunlei Su; Paul M Robben; Dan K Howe
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-01-29       Impact factor: 6.237

3.  Reliability of expert interpretation of retinal photographs for the diagnosis of toxoplasma retinochoroiditis.

Authors:  M R Stanford; L Gras; A Wade; R E Gilbert
Journal:  Br J Ophthalmol       Date:  2002-06       Impact factor: 4.638

4.  Acquired ocular toxoplasmosis in pregnancy.

Authors:  M Ramchandani; J B Weaver; D H M Joynson; P I Murray
Journal:  Br J Ophthalmol       Date:  2002-08       Impact factor: 4.638

Review 5.  Immunity and Toxoplasma retinochoroiditis.

Authors:  G R Wallace; M R Stanford
Journal:  Clin Exp Immunol       Date:  2008-06-28       Impact factor: 4.330

6.  Toxoplasmic retinochoroiditis presenting in childhood: clinical findings in a UK survey.

Authors:  M R Stanford; H K Tan; R E Gilbert
Journal:  Br J Ophthalmol       Date:  2006-08-09       Impact factor: 4.638

7.  Clinical manifestation and prognosis of active ocular toxoplasmosis in Iran.

Authors:  Farzan Kianersi; Afsaneh Naderi Beni; Zahra Naderi Beni
Journal:  Int Ophthalmol       Date:  2012-06-26       Impact factor: 2.031

8.  CD4+ T cells in the pathogenesis of murine ocular toxoplasmosis.

Authors:  Fangli Lu; Shiguang Huang; Lloyd H Kasper
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

9.  Molecular pathology of primary intraocular lymphoma.

Authors:  Chi-Chao Chan
Journal:  Trans Am Ophthalmol Soc       Date:  2003

10.  Additional haplogroups of Toxoplasma gondii out of Africa: population structure and mouse-virulence of strains from Gabon.

Authors:  Aurélien Mercier; Sébastien Devillard; Barthélémy Ngoubangoye; Henri Bonnabau; Anne-Laure Bañuls; Patrick Durand; Bettina Salle; Daniel Ajzenberg; Marie-Laure Dardé
Journal:  PLoS Negl Trop Dis       Date:  2010-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.